Human Chorionic Gonadotropin (hCG) Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066191
  • May 2021
  • Pharmaceuticals
  • 148 Pages
Download Sample
The Human Chorionic Gonadotropin (hCG) Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Merck & Co, Inc, Ferring B. V, Fresenius Kabi AG, Cigna, Sun Pharmaceutical Industries Ltd, Lee BioSolutions Inc, Sanzyme, Scrippslabs, Lupin AB, Prospec-Tany Technogene Ltd
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Human Chorionic Gonadotropin (hCG) market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Human Chorionic Gonadotropin (hCG) market is expected to attain Pre COVID-19 levels by mid-2022.

Human Chorionic Gonadotropin (hCG) Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Human Chorionic Gonadotropin (hCG) market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Human Chorionic Gonadotropin (hCG) Market Competitive and Premeditated Analysis
In the Human Chorionic Gonadotropin (hCG) report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Human Chorionic Gonadotropin (hCG) research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Human Chorionic Gonadotropin (hCG) Market:
The Human Chorionic Gonadotropin (hCG) market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Merck & Co, Inc, Ferring B. V, Fresenius Kabi AG, Cigna, Sun Pharmaceutical Industries Ltd, Lee BioSolutions Inc, Sanzyme, Scrippslabs, Lupin AB, Prospec-Tany Technogene Ltd

The Human Chorionic Gonadotropin (hCG) market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Human Chorionic Gonadotropin (hCG) Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Human Chorionic Gonadotropin (hCG) market:
by Technology
Natural Source Extraction
Recombinant Technology
Therapeutic Area
Female Infertility Treatment
Male Hypogonadism
Oligospermic Treatment
Others
End User
Fertility Clinics
Research Institutions
Others

Regional Analysis of the Human Chorionic Gonadotropin (hCG) market:
The Human Chorionic Gonadotropin (hCG) market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Human Chorionic Gonadotropin (hCG) report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Human Chorionic Gonadotropin (hCG) market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Human Chorionic Gonadotropin (hCG) market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Human Chorionic Gonadotropin (hCG) market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Human Chorionic Gonadotropin (hCG) market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Human Chorionic Gonadotropin (hCG) market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Human Chorionic Gonadotropin (hCG) market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Human Chorionic Gonadotropin (hCG) market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Human Chorionic Gonadotropin (hCG) market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Merck & Co, Inc
  • Ferring B. V
  • Fresenius Kabi AG
  • Cigna
  • Sun Pharmaceutical Industries Ltd
  • Lee BioSolutions Inc
  • Sanzyme
  • Scrippslabs
  • Lupin AB
  • Prospec-Tany Technogene Ltd
  • Natural Source Extraction
  • Recombinant Technology
  • Fertility Clinics
  • Research Institutions
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Human Chorionic Gonadotropin (hCG) Market Snapshot
          2.1.1. Global Human Chorionic Gonadotropin (hCG) Market By Technology,2019
               2.1.1.1.Natural Source Extraction
               2.1.1.2.Recombinant Technology
          2.1.2. Global Human Chorionic Gonadotropin (hCG) Market By End User,2019
               2.1.2.1.Fertility Clinics
               2.1.2.2.Research Institutions
               2.1.2.3.Others
          2.1.3. Global Human Chorionic Gonadotropin (hCG) Market By End-use,2019
          2.1.4. Global Human Chorionic Gonadotropin (hCG) Market By Geography,2019

3. Global Human Chorionic Gonadotropin (hCG) Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Human Chorionic Gonadotropin (hCG) Market Size (US$), By Technology, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Technology, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Technology, 2020
     4.2. Global Human Chorionic Gonadotropin (hCG) Market Size (US$), By Technology, 2018 – 2028

5. Global Human Chorionic Gonadotropin (hCG) Market Size (US$), By End User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End User, 2020
     5.2. Global Human Chorionic Gonadotropin (hCG) Market Size (US$), By End User, 2018 – 2028

6. Global Human Chorionic Gonadotropin (hCG) Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Human Chorionic Gonadotropin (hCG) Market Size (US$), By End-use, 2018 – 2028

7. Global Human Chorionic Gonadotropin (hCG) Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Human Chorionic Gonadotropin (hCG) Market Analysis, 2018 – 2028 
          7.2.1. North America Human Chorionic Gonadotropin (hCG) Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Human Chorionic Gonadotropin (hCG) Market Size (US$), By Technology, 2018 – 2028
          7.2.3. North America Human Chorionic Gonadotropin (hCG) Market Size (US$), By End User, 2018 – 2028
          7.2.4. North America Human Chorionic Gonadotropin (hCG) Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Human Chorionic Gonadotropin (hCG) Market Analysis, 2018 – 2028 
          7.3.1.  Europe Human Chorionic Gonadotropin (hCG) Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Human Chorionic Gonadotropin (hCG) Market Size (US$), By Technology, 2018 – 2028
          7.3.3. Europe Human Chorionic Gonadotropin (hCG) Market Size (US$), By End User, 2018 – 2028
          7.3.4. Europe Human Chorionic Gonadotropin (hCG) Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Human Chorionic Gonadotropin (hCG) Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Human Chorionic Gonadotropin (hCG) Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Human Chorionic Gonadotropin (hCG) Market Size (US$), By Technology, 2018 – 2028
          7.4.3. Asia Pacific Human Chorionic Gonadotropin (hCG) Market Size (US$), By End User, 2018 – 2028
          7.4.4. Asia Pacific Human Chorionic Gonadotropin (hCG) Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Human Chorionic Gonadotropin (hCG) Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Human Chorionic Gonadotropin (hCG) Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Human Chorionic Gonadotropin (hCG) Market Size (US$), By Technology, 2018 – 2028
          7.5.3. Latin America Human Chorionic Gonadotropin (hCG) Market Size (US$), By End User, 2018 – 2028
          7.5.4. Latin America Human Chorionic Gonadotropin (hCG) Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Human Chorionic Gonadotropin (hCG) Market Analysis, 2018 – 2028 
          7.6.1.  MEA Human Chorionic Gonadotropin (hCG) Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Human Chorionic Gonadotropin (hCG) Market Size (US$), By Technology, 2018 – 2028
          7.6.3. MEA Human Chorionic Gonadotropin (hCG) Market Size (US$), By End User, 2018 – 2028
          7.6.4. MEA Human Chorionic Gonadotropin (hCG) Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Human Chorionic Gonadotropin (hCG) Providers
        8.4.1 Merck & Co, Inc
                8.4.1.1 Business Description
                8.4.1.2 Merck & Co, Inc Geographic Operations
                8.4.1.3 Merck & Co, Inc Financial Information
                8.4.1.4 Merck & Co, Inc Product Positions/Portfolio
                8.4.1.5 Merck & Co, Inc Key Developments
        8.4.2 Ferring B. V
                8.4.2.1 Business Description
                8.4.2.2 Ferring B. V Geographic Operations
                8.4.2.3 Ferring B. V Financial Information
                8.4.2.4 Ferring B. V Product Positions/Portfolio
                8.4.2.5 Ferring B. V Key Developments
        8.4.3 Fresenius Kabi AG
                8.4.3.1 Business Description
                8.4.3.2 Fresenius Kabi AG Geographic Operations
                8.4.3.3 Fresenius Kabi AG Financial Information
                8.4.3.4 Fresenius Kabi AG Product Positions/Portfolio
                8.4.3.5 Fresenius Kabi AG Key Developments
        8.4.4 Cigna
                8.4.4.1 Business Description
                8.4.4.2 Cigna Geographic Operations
                8.4.4.3 Cigna Financial Information
                8.4.4.4 Cigna Product Positions/Portfolio
                8.4.4.5 Cigna Key Developments
        8.4.5 Sun Pharmaceutical Industries Ltd
                8.4.5.1 Business Description
                8.4.5.2 Sun Pharmaceutical Industries Ltd Geographic Operations
                8.4.5.3 Sun Pharmaceutical Industries Ltd Financial Information
                8.4.5.4 Sun Pharmaceutical Industries Ltd Product Positions/Portfolio
                8.4.5.5 Sun Pharmaceutical Industries Ltd Key Developments
        8.4.6 Lee BioSolutions Inc
                8.4.6.1 Business Description
                8.4.6.2 Lee BioSolutions Inc Geographic Operations
                8.4.6.3 Lee BioSolutions Inc Financial Information
                8.4.6.4 Lee BioSolutions Inc Product Positions/Portfolio
                8.4.6.5 Lee BioSolutions Inc Key Developments
        8.4.7 Sanzyme
                8.4.7.1 Business Description
                8.4.7.2 Sanzyme Geographic Operations
                8.4.7.3 Sanzyme Financial Information
                8.4.7.4 Sanzyme Product Positions/Portfolio
                8.4.7.5 Sanzyme Key Developments
        8.4.8 Scrippslabs
                8.4.8.1 Business Description
                8.4.8.2 Scrippslabs Geographic Operations
                8.4.8.3 Scrippslabs Financial Information
                8.4.8.4 Scrippslabs Product Positions/Portfolio
                8.4.8.5 Scrippslabs Key Developments
        8.4.9 Lupin AB
                8.4.9.1 Business Description
                8.4.9.2 Lupin AB Geographic Operations
                8.4.9.3 Lupin AB Financial Information
                8.4.9.4 Lupin AB Product Positions/Portfolio
                8.4.9.5 Lupin AB Key Developments
        8.4.10 Prospec-Tany Technogene Ltd
                8.4.10.1 Business Description
                8.4.10.2 Prospec-Tany Technogene Ltd Geographic Operations
                8.4.10.3 Prospec-Tany Technogene Ltd Financial Information
                8.4.10.4 Prospec-Tany Technogene Ltd Product Positions/Portfolio
                8.4.10.5 Prospec-Tany Technogene Ltd Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Human Chorionic Gonadotropin (hCG) Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Human Chorionic Gonadotropin (hCG) Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Human Chorionic Gonadotropin (hCG) Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Human Chorionic Gonadotropin (hCG) Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Human Chorionic Gonadotropin (hCG) Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Human Chorionic Gonadotropin (hCG) Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Human Chorionic Gonadotropin (hCG) Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Human Chorionic Gonadotropin (hCG) Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Human Chorionic Gonadotropin (hCG) Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Human Chorionic Gonadotropin (hCG) Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Human Chorionic Gonadotropin (hCG) Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Human Chorionic Gonadotropin (hCG) Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Human Chorionic Gonadotropin (hCG) Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Human Chorionic Gonadotropin (hCG) Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Human Chorionic Gonadotropin (hCG) Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Human Chorionic Gonadotropin (hCG) Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Human Chorionic Gonadotropin (hCG): Market Segmentation 
FIG. 2 Global Human Chorionic Gonadotropin (hCG) Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Human Chorionic Gonadotropin (hCG) Market, By Technology, 2019 (US$ Mn) 
FIG. 5 Global Human Chorionic Gonadotropin (hCG) Market, By End User, 2019 (US$ Mn) 
FIG. 6 Global Human Chorionic Gonadotropin (hCG) Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Human Chorionic Gonadotropin (hCG) Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Human Chorionic Gonadotropin (hCG) Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Human Chorionic Gonadotropin (hCG) Providers, 2019
FIG. 11 Global Human Chorionic Gonadotropin (hCG) Market Revenue Contribution, By Technology, 2019 & 2028 (Value %) 
FIG. 12 Global Human Chorionic Gonadotropin (hCG) Market Revenue Contribution, By End User, 2019 & 2028 (Value %) 
FIG. 13 Global Human Chorionic Gonadotropin (hCG) Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Human Chorionic Gonadotropin (hCG) Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Human Chorionic Gonadotropin (hCG) Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Human Chorionic Gonadotropin (hCG) Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Human Chorionic Gonadotropin (hCG) Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Human Chorionic Gonadotropin (hCG) Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Human Chorionic Gonadotropin (hCG) market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Human Chorionic Gonadotropin (hCG) Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Human Chorionic Gonadotropin (hCG) Market Value, By Segment1, 2018 – 2028
TABLE  North America Human Chorionic Gonadotropin (hCG) Market Value, By Segment2, 2018 – 2028
TABLE  North America Human Chorionic Gonadotropin (hCG) Market Value, By Country, 2018 – 2028
TABLE  Europe Human Chorionic Gonadotropin (hCG) Market Value, By Segment1, 2018 – 2028
TABLE  Europe Human Chorionic Gonadotropin (hCG) Market Value, By Segment2, 2018 – 2028
TABLE  Europe Human Chorionic Gonadotropin (hCG) Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Human Chorionic Gonadotropin (hCG) Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Human Chorionic Gonadotropin (hCG) Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Human Chorionic Gonadotropin (hCG) Market Value, By Country, 2018 – 2028
TABLE  Latin America Human Chorionic Gonadotropin (hCG) Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Human Chorionic Gonadotropin (hCG) Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Human Chorionic Gonadotropin (hCG) Market Value, By Country, 2018 – 2028
TABLE  MEA Human Chorionic Gonadotropin (hCG) Market Value, By Segment1, 2018 – 2028
TABLE  MEA Human Chorionic Gonadotropin (hCG) Market Value, By Segment2, 2018 – 2028
TABLE  MEA Human Chorionic Gonadotropin (hCG) Market Value, By Country, 2018 – 2028
TABLE  Merck & Co, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ferring B. V: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Fresenius Kabi AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cigna: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sun Pharmaceutical Industries Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Lee BioSolutions Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanzyme: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Scrippslabs: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Lupin AB: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Prospec-Tany Technogene Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Human Chorionic Gonadotropin (hCG) Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Human Chorionic Gonadotropin (hCG) Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Human Chorionic Gonadotropin (hCG) Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Human Chorionic Gonadotropin (hCG) Market, By Geography, 2019 (US$ Mn)
FIG.  Global Human Chorionic Gonadotropin (hCG) Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Human Chorionic Gonadotropin (hCG) Providers, 2016
FIG.  Global Human Chorionic Gonadotropin (hCG) Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Recombinant Technology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Human Chorionic Gonadotropin (hCG) Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Research Institutions Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Human Chorionic Gonadotropin (hCG) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Human Chorionic Gonadotropin (hCG) Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Human Chorionic Gonadotropin (hCG) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Human Chorionic Gonadotropin (hCG) Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Human Chorionic Gonadotropin (hCG) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Human Chorionic Gonadotropin (hCG) Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Human Chorionic Gonadotropin (hCG) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Human Chorionic Gonadotropin (hCG) Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Human Chorionic Gonadotropin (hCG) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Human Chorionic Gonadotropin (hCG) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Human Chorionic Gonadotropin (hCG) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Human Chorionic Gonadotropin (hCG) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Human Chorionic Gonadotropin (hCG) Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Human Chorionic Gonadotropin (hCG) Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Human Chorionic Gonadotropin (hCG) Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Human Chorionic Gonadotropin (hCG) Market Value, 2018 – 2028, (US$ Mn)